Results 91 to 100 of about 1,650 (186)

ePoster

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

FORMULATION AND DESIGN OF TASTE MASKED QUETIAPINE FUMARATE ORALLY FAST DISINTEGRATING TABLETS BY SUBLIMATION METHOD

, 2013
Quetiapine Fumarate bioavailability is 9%. Used in the treatment of schizophrenia. It is preferable to administer in the form of fast disintegrating tablets used for depressive episodes, acute manic episodes associated with bipolar I disorder at a short ...
Mettu Srikanth Reddy1, N. G. Raghavendra Rao*1, Krishna. D2
core   +1 more source

SOLUBILITY AND THERMODYNAMIC MODELING OF QUETIAPINE FUMARATE IN SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS)

, 2018
Objective: The present study gives emphasis on the development of self-nanoemulsifying drug delivery system (SNEDDS) of poorly water-soluble drug using Apelblat model.
Talele, S. G., Derle, D. V.
core  

Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). .

, 1999
The interplay between dopamine and glutamate appears to be relevant in the etiopathology of schizophrenia. Although currently used antipsychotics do not interact with glutamatergic receptors, previous results have demonstrated that the expression ...
BLOM, Johanna Maria Catharina, P. MUZZIOLI, BRUNELLO, Nicoletta, M. A. RIVA, G. RACAGNI, N. Brunello, J. M. Blom, F. Tascedda, E. LOVATI, TASCEDDA, Fabio, M.A. Riva   +10 more
core   +1 more source

Dependence on zopiclone: a case report

Frontiers in Psychiatry
BackgroundZopiclone, a cyclopyrrolone derivative, is commonly employed for the short-term treatment of different types of insomnia. In comparison to benzodiazepines, Zopiclone appears to have a lower risk of abuse potential and withdrawal symptoms ...
Nana Guo, Nana Guo, Xuhui Zhou, Xuhui Zhou   +3 more
doaj   +1 more source

Central Retinal Vein Occlusion in 2 Patients Using Antipsychotic Drugs

Case Reports in Ophthalmology, 2017
Purpose: To report our findings in 2 patients who developed a central retinal vein occlusion (CRVO) and were chronic users of antipsychotic medications.
Koichiro Taki, Teruyo Kida, Masanori Fukumoto, Takaki Sato, Hidehiro Oku, Tsunehiko Ikeda   +5 more
doaj   +1 more source

Influence of Plasdone^™ S630 Ultra-an Improved Copovidone on the Processability and Oxidative Degradation of Quetiapine Fumarate Amorphous Solid Dispersions Prepared via Hot-Melt Extrusion Technique. [PDF]

AAPS PharmSciTech, 2021
Butreddy A, Sarabu S, Bandari S, Batra A, Lawal K, Chen NN, Bi V, Durig T, Repka MA.   +8 more
europepmc   +1 more source

Impact of hydrophilic binders on stability of lipid-based sustained release matrices of quetiapine fumarate by the continuous twin screw melt granulation technique. [PDF]

Adv Powder Technol, 2021
Nyavanandi D, Kallakunta VR, Sarabu S, Butreddy A, Narala S, Bandari S, Repka MA.   +6 more
europepmc   +1 more source

Predictive factors of remission for treatment-resistant major depressive disorder (MDD) during treatment with extended-release quetiapine fumarate(quetiapine XR)

, 2010
Aim: To explore predictors of remission for patients with treatment-resistant MDD receiving quetiapine XR. Methods: Post-hoc analysis of data from a 6-week, randomised, open-label, rater-blinded study (NCT00789854) in adults with treatment-resistant ...
Dencker-Vansvik, E., Montgomery, S., Köhler, J., Dell'Osso, L., Jørgensen, L., Kasper, S., Baune, B.T., Bauer, M., Pichot, W.   +8 more
core   +1 more source

Self-emulsifying Drug Delivery System for Improved Dissolution and Oral Absorption of Quetiapine Fumarate: Investigation of Drug Release Mechanism and In-vitro Intestinal Permeability. [PDF]

Iran J Pharm Res, 2021
Ayed OBH, Lassoued MA, Bahloul B, Sfar S.   +3 more
europepmc   +1 more source